Lv4
424 积分 2024-09-24 加入
Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial
26天前
已完结
Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial
26天前
已完结
Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity
26天前
已完结
Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial
1个月前
已完结
Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial
1个月前
已完结
HTD1801 in Combination with Metformin for Type 2 Diabetes
1个月前
已完结
HTD1801 in Combination with Metformin for Type 2 Diabetes
1个月前
已完结
Long-term safety of oral orforglipron in Japanese participants with type 2 diabetes (ACHIEVE-J): a multicentre, randomised, open-label, parallel-group phase 3 trial
1个月前
已完结
Orforglipron Added to Titrated Insulin Glargine in Type 2 Diabetes
1个月前
已关闭
Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study
1个月前
已完结
皖公网安备34019202002308
